TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SCLX

Scilex Holding Company

Healthcare · Drug Manufacturers - General

5.00$ -6.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Scilex Holding Company (SCLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 7.6 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SCLX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
10 13 11 16 14 15 5.0 9.9 11 4.8 8.6 7.6 32
3.4 5.6 3.8 4.4 3.8 4.7 1.4 3.3 3.3 2.6 4.4 6.5 17
6.7 7.9 7.0 12 11 10 3.6 6.6 7.2 2.2 4.2 1.1 15
4.1 2.7 3.1 2.0 2.3 2.2 2.5 6.2 3.9 8.2 3.2 3.3 19
40 24 29 25 30 35 28 20 189 30 31 28 278
46 26 27 28 37 39 32 27 194 42 36 31 303
-39 -18 -19 -16 -22 -28 -28 -21 -187 -37 -32 -29 -286
0.5 0.6 0.5 0.6 0.6 0.3 2.5 2.7 2.8 3.5 3.8 6.1 16
-36 -21 -24 -38 -4.4 -6.5 -26 -44 -258 -46 -46 -115 -465
0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
-36 -21 -24 -38 -4.4 -6.5 -26 -86 -257 -33 -43 -114 -447
-34 -20 -23 -36 -5.2 -23 -40 -254 -39 -27

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?